Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment

IMPORTANCE: Prasugrel was approved at a lower dose in 2014 in Japan than in the West because East Asian patients are considered more susceptible to bleeding than Western patients. However, real-world outcomes with low-dose prasugrel treatment remain unclear. OBJECTIVE: To investigate the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Satoshi, Sawano, Mitsuaki, Sandhu, Alexander T., Heidenreich, Paul A., Shiraishi, Yasuyuki, Ikemura, Nobuhiro, Ueno, Koji, Suzuki, Masahiro, Numasawa, Yohei, Fukuda, Keiichi, Kohsaka, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118520/
https://www.ncbi.nlm.nih.gov/pubmed/32239221
http://dx.doi.org/10.1001/jamanetworkopen.2020.2004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118520/
https://www.ncbi.nlm.nih.gov/pubmed/32239221
http://dx.doi.org/10.1001/jamanetworkopen.2020.2004

Ejemplares similares